Proceeds from the financing will help scale up 1910’s AI and biological automation platforms, building its team, expanding partnerships with biopharma companies, and advancing its pipeline of therapeutic programs . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge